LCLA vs LK4B: Side-by-Side Comparison
Compare PT Kalbe Farma Tbk (LCLA) and LIPPO KARAWACI (LK4B) side by side: market cap EUR 2.13B vs EUR 460.70M. Financials, growth and model signals on Bullrun.
| Metric | LCLA | LK4B |
|---|---|---|
| Company | PT Kalbe Farma Tbk | LIPPO KARAWACI |
| Country / Exchange | Indonesia · F | Indonesia · MU |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical Care Facilities |
| Market cap | EUR 2.13B | EUR 460.70M |
| P/E ratio | — | — |
| Dividend yield | 2.93% | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | — |
| Revenue growth YoY | — | — |
| Net income | — | — |
| Gross margin | — | — |
| Diluted EPS | — | — |